期刊
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY
卷 23, 期 5, 页码 462-473出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.rpor.2018.07.002
关键词
NCT; BNCT; GdNCT; SNCT; Delivery system(252)Cf
Neutron capture therapy (NCT) is a targeted radiotherapy for cancer treatment. In this method, neutrons with a spectra/specific energy (depending on the type of agent used for NCT) are captured with an agent that has a high cross-section with these neutrons. There are some agents that have been proposed in NCT including B-10, Gd-157 and S-33. Among these agents, only B-10 is used in clinical trials. Application of Gd-157 is limited to in-vivo and in-vitro research. In addition, S-33 has been applied in the field of Monte Carlo simulation. In BNCT, the only two delivery agents which are presently applied in clinical trials are BPA and BSH, but other delivery systems are being developed for more effective treatment in NCT. Neutron sources used in NCT are fission reactors, accelerators, and Cf-252. Among these, fission reactors have the most application in NCT. So far, BNCT has been applied to treat various cancers including glioblastoma multiforme, malignant glioma, malignant meningioma, liver, head and neck, lung, colon, melanoma, thyroid, hepatic, gastrointestinal cancer, and extra-mammary Paget's disease. This paper aims to review physical, dosimetric and clinical aspects as well as delivery systems in NCT for various agents. (C) 2018 Greater Poland Cancer Centre. Published by Elsevier Sp. z o.o. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据